Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+9,022,085
Put/Call ratio
27%
SEC-reported price per share
$69.55
Number of holders
197
Value change
+$791,360,837
Number of buys
115
Open additional details 1 more signal available
Number of sells
88
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
213,001,347

Security key

86366E106

Report period

Q4 2025

Institutions

197

Top holders

10

Ownership snapshot

Top reported holders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 15% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
WELLINGTON MANAGEMENT GROUP LLP 10%
Avoro Capital Advisors LLC 9.4%
JANUS HENDERSON GROUP PLC 7.7%
Deep Track Capital, LP 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
15%
$2,163,883,695
31,112,634 shares
+$776,609,280 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP
13D/G 13F
Company
10%
$1,481,942,431
21,365,952 shares
+$50,941,729 31 Dec 2025
Avoro Capital Advisors LLC
13D/G 13F
Company
9.4%
$454,066,620
16,216,665 shares
$0 30 Sep 2025
JANUS HENDERSON GROUP PLC
13F 13D/G
Company
7.7%
from 13D/G
$124,603,170
4,448,826 shares
30 Sep 2025
Deep Track Capital, LP
13D/G 13F
Company
6%
$855,579,599
12,335,346 shares
-$21,646,354 31 Dec 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
4.9%
$723,914,898
10,437,066 shares
+$57,243,848 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
197
Shares
65,776,439
Rows available
197
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
155
Q4 2025 holders
197
Holder diff
42
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .